Home
News
Create
Screeners
Insights
Brooks Laboratories
74.
47
-1.08
(-1.43%)
Market Cap
₹219.37 Cr
PE Ratio
10.38
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.43%
1M
+9.34%
6M
-51.07%
1Y
-38.42%
5Y
+20.87%
View Company Insights
Latest news about Brooks Laboratories
Brooks Laboratories Limited Receives ITAT Orders Dismissing Appeals for Assessment Years 2012-13, 2014-15 and 2016-17
Jan 30, 2026
Brooks Laboratories Limited disclosed that the Income Tax Appellate Tribunal (ITAT) Chandigarh Bench dismissed the company's appeals for Assessment Years 2012-13, 2014-15 and 2016-17. The appeals were filed against orders from the Commissioner of Income Tax (Appeals) and National Faceless Appeal Centre, where the company had received partial relief. Despite the dismissal, Brooks Laboratories stated there is no material impact on its financials, operations, or other business activities.
Brooks Laboratories Limited Board Meeting Scheduled for February 6, 2026 to Consider Q3FY26 Unaudited Financial Results
Jan 29, 2026
Brooks Laboratories Receives Credit Rating Upgrade, Reflecting Improved Financial Outlook
Nov 12, 2025
Brooks Steriscience Approves Multi-Entity Merger Scheme to Consolidate Sterile Injectable Operations
Sep 26, 2025
Brooks Laboratories Reports Robust Q1 FY26 Results with 265.06 Lakh Net Profit
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation